Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/62415
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRana, Anita-
dc.contributor.authorBajwa, Harjit Kaur-
dc.date.accessioned2023-08-09T04:44:26Z-
dc.date.available2023-08-09T04:44:26Z-
dc.date.issued2023-08-
dc.identifier.issn0022-4456 (Print); 0975-1084 (Online)-
dc.identifier.urihttp://nopr.niscpr.res.in/handle/123456789/62415-
dc.description805-817en_US
dc.description.abstractEvery year, more than 12 million people are diagnosed with cancer worldwide. Cancer diagnosis is difficult for anybody to bear, and dealing with treatment is sometimes more complicated than the disease itself. When it comes to cancer treatment choices, chemotherapy is the most well-known since it is frequently used and recommended by specialists all over the world. On the other hand, chemotherapy is recognized for destroying healthy cells, and this destruction led to several negative impacts on the body. Recent advancements in biology have allowed scientists to better study the possible use of other methods, including phytotherapy and apitherapy for treating or managing many malignant conditions. Phytotherapy and apitherapy are among the best alternatives to chemotherapy as plants and honeybee products are chief sources of phytochemicals with anticancer properties. For example, hesperidin, melittin, apamin, artepillin, 10-hydroxy-2-decenoic acid (10-HDA), Major Royal Jelly Proteins (MRJP), jelleins, royalisin and caffeic acid phenethyl ester are important plant and bee engineered product constituents which by inducing apoptosis and arresting cell cycle control the proliferation of cancer cells. In general, this review highlights problems related to cancer treatment using chemicals. It discusses phytotherapy and apitherapy as an alternative to chemotherapy, while plants and bee products rich in natural anticancer compounds have greater potency to treat cancer.en_US
dc.language.isoenen_US
dc.publisherNIScPR-CSIR,Indiaen_US
dc.sourceJSIR Vol.82(08) [August 2023]en_US
dc.subjectApitherapyen_US
dc.subjectBee engineered productsen_US
dc.subjectChemotherapyen_US
dc.subjectPhytochemicalsen_US
dc.subjectPhytotherapyen_US
dc.subjectSide effectsen_US
dc.titleTherapeutics of Bioactive Compounds from Medicinal Plants and Honeybee Products against Canceren_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.56042/jsir.v82i08.1895en_US
Appears in Collections:JSIR Vol.82(08) [August 2023]

Files in This Item:
File Description SizeFormat 
JSIR 82(08) 805-817.pdf2.43 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.